Search Results - "RAIA, V."

Achromobacter xylosoxidans respiratory tract infection in cystic fibrosis patients by Lambiase, A., Catania, M. R., del Pezzo, M., Rossano, F., Terlizzi, V., Sepe, A., Raia, V.

“…The aims of this study were to evaluate the frequency of Achromobacter xylosoxidans infection in a cohort of cystic fibrosis patients, to investigate…”
Get full text

A novel treatment of cystic fibrosis acting on-target: cysteamine plus epigallocatechin gallate for the autophagy-dependent rescue of class II-mutated CFTR by Tosco, A, De Gregorio, F, Esposito, S, De Stefano, D, Sana, I, Ferrari, E, Sepe, A, Salvadori, L, Buonpensiero, P, Di Pasqua, A, Grassia, R, Leone, C A, Guido, S, De Rosa, G, Lusa, S, Bona, G, Stoll, G, Maiuri, M C, Mehta, A, Kroemer, G, Maiuri, L, Raia, V

“…We previously reported that the combination of two safe proteostasis regulators, cysteamine and epigallocatechin gallate (EGCG), can be used to improve…”
Get full text

Elevated sweat chloride test: is it always cystic fibrosis? by Cimbalo, C, Tosco, A, Terlizzi, V, Sepe, A, Castaldo, A, Salvadori, L, Raia, V

“…The sweat chloride test (ST) is the gold standard for cystic fibrosis (CF) diagnosis in symptomatic patients, within the newborn screening and in the follow-up…”
Get full text

An overview of international literature from cystic fibrosis registries: 1. Mortality and survival studies in cystic fibrosis by Buzzetti, R, Salvatore, D, Baldo, E, Forneris, M.P, Lucidi, V, Manunza, D, Marinelli, I, Messore, B, Neri, A.S, Raia, V, Furnari, M.L, Mastella, G

“…Abstract Patient registries are organized systems of data collection for scientific, clinical or health strategy purposes. Aims of our review were to document…”
Get full text

Disease-relevant proteostasis regulation of cystic fibrosis transmembrane conductance regulator by Villella, V R, Esposito, S, Bruscia, E M, Vicinanza, M, Cenci, S, Guido, S, Pettoello-Mantovani, M, Carnuccio, R, De Matteis, M A, Luini, A, Maiuri, M C, Raia, V, Kroemer, G, Maiuri, L

“…Mismanaged protein trafficking by the proteostasis network contributes to several conformational diseases, including cystic fibrosis, the most frequent lethal…”
Get full text

Intestinal inflammation is a frequent feature of cystic fibrosis and is reduced by probiotic administration by Bruzzese, E., Raia, V., Gaudiello, G., Polito, G., Buccigrossi, V., Formicola, V., Guarino, A.

“…Summary Aims : To assess the incidence of intestinal inflammation in children with cystic fibrosis and to investigate whether probiotics decrease it. Study…”
Get full text

Lumevis ™: a new medical device to prepare patients for esophagogastroduodenoscopy. Experimental clinical study by Geraci, G, Palumbo, V D, Fazzotta, S, Raia, V, Damiano, G, Di Vita, G, Lo Monte, A I

“…Esophagogastroduodenoscopy (EGDS) is the gold standard exam for upper gastrointestinal diseases. EGDS is very important in Early Gastric Cancer diagnosis and…”
Get more information

A novel treatment of cystic fibrosis acting on-target: cysteamine plus epigallocatechin gallate for the autophagy-dependent rescue of class II-mutated CFTR by Tosco, A, De Gregorio, F, Esposito, S, De Stefano, D, Sana, I, Ferrari, E, Sepe, A, Salvadori, L, Buonpensiero, P, Di Pasqua, A, Grassia, R, Leone, C A, Guido, S, De Rosa, G, Lusa, S, Bona, G, Stoll, G, Maiuri, M C, Mehta, A, Kroemer, G, Maiuri, L, Raia, V

“…This corrects the article DOI: 10.1038/cdd.2016.22…”
Get full text

Screening of glucose metabolism derangements in pediatric cystic fibrosis patients: how, when, why by Franzese, Adriana, Mozzillo, E., Fattorusso, V., Raia, V., Valerio, G.

“…Diabetes mellitus is the most common comorbidity in cystic fibrosis (CF), occurring in a variable number of children and adolescents. Glucose metabolism…”
Get full text

An "ex vivo model" contributing to the diagnosis and evaluation of new drugs in cystic fibrosis by Di Lullo, A M, Scorza, M, Amato, F, Comegna, M, Raia, V, Maiuri, L, Ilardi, G, Cantone, E, Castaldo, G, Iengo, M

“…Cystic fibrosis (CF) is an autosomal recessive disease caused by mutations in the cystic fibrosis transmembrane regulator (CFTR) gene. About 2000 mutations…”
Get full text

Scar endometriosis: not a rare cause for a painful scar by Buscemi, S, Maiorana, A, Fazzotta, S, Incandela, D, Palumbo, V D, Damiano, G, Maffongelli, A, Messina, M, Bisso, C, Anzelmo, G, Curione, F, Cantavenera, V, Bellomo, E, Raia, V E, Scimeca, R, Geraci, G, Cudia, B M, Lo Monte, A I

“…High suspicion of scar endometriosis are painful no-dule in the abdominal scar. Wide surgical excision is the treatment of choice. Endometriosis has been…”
Get more information

Prediction of acute pancreatitis risk based on PIP score in children with cystic fibrosis by Terlizzi, V, Tosco, A, Tomaiuolo, R, Sepe, A, Amato, N, Casale, A, Mercogliano, C, De Gregorio, F, Improta, F, Elce, A, Castaldo, G, Raia, V

“…Abstract Background Currently no tools to predict risk of acute (AP) and recurrent pancreatitis (ARP) in children with cystic fibrosis (CF) are available. We…”
Get full text

Randomized, single blind, controlled trial of inhaled glutathione vs placebo in patients with cystic fibrosis by Calabrese, C, Tosco, A, Abete, P, Carnovale, V, Basile, C, Magliocca, A, Quattrucci, S, De Sanctis, S, Alatri, F, Mazzarella, G, De Pietro, L, Turino, C, Melillo, E, Buonpensiero, P, Di Pasqua, A, Raia, V

“…Abstract Background In cystic fibrosis (CF) the defective CF transmembrane conductance regulator protein may be responsible for the impaired transport of…”
Get full text

WS15.6 Short term effects of Positive Expiratory Pressure mask breathing on distribution of lung ventilation in cystic fibrosis patients: a preliminary report with electrical impedance tomography by Buonpensiero, P, Gregorio, F. De, Pasqua, A. Di, Tosco, A, d'Ippolito, M, Pasqua, M. Di, Cipolletta, B, Fiorentino, G, Raia, V

Get full text

WS10.6 Intra-individual biological variation in sweat chloride concentrations by Cirilli, N, Raia, V, De Gregorio, F, Di Pietro, M, Tosco, A, Salvadori, L, Sepe, A, Buzzetti, R, Minicuci, N, Rocco, I, Castaldo, G, Nardiello, P

Get full text

Insulin production and resistance in cystic fibrosis: Effect of age, disease activity, and genotype by Street, M. E., Spaggiari, C., Ziveri, M. A., Rossi, M., Volta, C., Viani, I., Grzincich, G. L., Sartori, C., Zanzucchi, M., Raia, V., Terzi, C., Pisi, G., Zanetti, E., Boguszewski, M. C. S., Kamoi, T. O., Bernasconi, S.

“…Aim: To assess the major determinants of glucose tolerance between age, genotype, and clinical status in cystic fibrosis (CF) patients, and study if defects of…”
Get full text

Inhibition of p38 mitogen activated protein kinase controls airway inflammation in cystic fibrosis by Raia, V, Maiuri, L, Ciacci, C, Ricciardelli, I, Vacca, L, Auricchio, S, Cimmino, M, Cavaliere, M, Nardone, M, Cesaro, A, Malcolm, J, Quaratino, S, Londei, M

“…Background: Cystic fibrosis (CF) airways are characterised by chronic inflammation, increased interleukin (IL)-8 secretion, and neutrophil activation which are…”
Get full text

55 CA-MRSA and HA-MRSA persistent infection and pulmonary function: a multicenter longitudinal study by Dolce, D, Campana, S, Ravenni, N, Camera, E, Neri, S, Cariani, L, Colombo, C, Fiscarelli, E.V, Lucidi, V, Raia, V, Iula, D.V, Braggion, C, Taccetti, G

Get full text

WS13.4 A novel treatment of cystic fibrosis acting on-target: cysteamine plus epigallocatechin gallate for the autophagy-dependent rescue of class II-mutated CFTR by Tosco, A, Gregorio, F. De, Esposito, S, Sepe, A, Salvadori, L, Buonpensiero, P, Pasqua, A. Di, Casale, A, Rosa, G. De, Stoll, G, Maiuri, M.C, Mehta, A, Kroemer, G, Maiuri, L, Raia, V

Get full text

The ESPGHAN Cystic Fibrosis Working Group: Defining DIOS and Constipation in Cystic Fibrosis With a Multicenter Study on the Incidence, Characteristics, and Treatment of DIOS by Raia, V, Fuiano, L, Staiano, A

Get full text